Acrivastine and pseudoephedrine and Trastuzumab-dkst
Determining the interaction of Acrivastine and pseudoephedrine and Trastuzumab-dkst and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Trastuzumab-dkst Intravenous
- Acrivastine and pseudoephedrine-Trasylol
- Acrivastine and pseudoephedrine-Travasol
- Acrivastine and pseudoephedrine-Travatan
- Acrivastine and pseudoephedrine-Travatan Z
- Acrivastine and pseudoephedrine-Travatan Z Ophthalmic Solution
- Trastuzumab-dkst-Actamin
- Trastuzumab-dkst-Actamin Maximum Strength
- Trastuzumab-dkst-Actemra
- Trastuzumab-dkst-Actemra (Tocilizumab (Intravenous))
- Trastuzumab-dkst-Actemra (Tocilizumab Auto-Injectors)
- Trastuzumab-dkst-Actemra (Tocilizumab Prefilled Syringes)